These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22404564)

  • 1. Vincristine modulates the expression of Ki67 and apoptosis in naturally occurring canine transmissible venereal tumor (TVT).
    Özalp GR; Zik B; Bastan A; Peker S; Özdemir-Salci ES; Bastan I; Darbaz I; Salar S; Karakas K
    Biotech Histochem; 2012 Jul; 87(5):325-30. PubMed ID: 22404564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
    Nak D; Nak Y; Cangul IT; Tuna B
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
    Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
    J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC; Valladão ML; Metze K
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
    Brown NO; Calvert C; MacEwen EG
    J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT).
    Hantrakul S; Klangkaew N; Kunakornsawat S; Tansatit T; Poapolathep A; Kumagai S; Poapolathep S
    J Vet Med Sci; 2014 Dec; 76(12):1549-53. PubMed ID: 25649934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine for treatment of transmissible venereal tumor in the dog--.
    Calvert CA; Leifer CE; MacEwen EG
    J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
    Amber EI; Henderson RA
    J Vet Intern Med; 1992; 6(5):300. PubMed ID: 1432905
    [No Abstract]   [Full Text] [Related]  

  • 9. Semen quality during vincristine treatment in dogs with transmissible venereal tumor.
    Saratsis P; Ypsilantis P; Tselkas K
    Theriogenology; 2000 Mar; 53(5):1185-92. PubMed ID: 10798495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
    Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
    Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of metastatic transmissible venereal tumour to skin of mammary region.
    Varughese EE; Singla VK; Ratnakaran U; Gandotra VK
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():366-9. PubMed ID: 23279540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissible venereal tumor: a retrospective study of 29 cases.
    Rogers KS; Walker MA; Dillon HB
    J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
    Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS
    Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
    Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
    J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Treatment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2.
    DEN Otter W; Hack M; Jacobs JJ; Tan JF; Rozendaal L; VAN Moorselaar RJ
    Anticancer Res; 2015 Jun; 35(6):3385-91. PubMed ID: 26026099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theriogenology question of the month. Transmissible venereal tumor (TVT).
    Hasler AH; Weber WT
    J Am Vet Med Assoc; 2000 May; 216(10):1557-9. PubMed ID: 10825939
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
    Amber EI; Henderson RA; Adeyanju JB; Gyang EO
    J Vet Intern Med; 1990; 4(3):144-7. PubMed ID: 2366223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
    Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
    Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up on chemotherapy of venereal tumors.
    Brown NO; MacEwen EG; Clavert C
    J Am Vet Med Assoc; 1980 Oct; 177(8):676. PubMed ID: 7440361
    [No Abstract]   [Full Text] [Related]  

  • 20. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
    Hiblu MA; Khabuli NM; Gaja AO
    Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.